Lipocine Inc — Dividend History & Yield (NASDAQ:LPCN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

News

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

Lipocine’s PPD drug trial continues after positive safety review

Lipocine reaches 80% enrollment in postpartum depression drug trial

Lipocine presents LPCN 2101 epilepsy candidate data at annual AES meeting

Lipocine stock price target lowered to $7 at H.C. Wainwright on PPD trial timeline

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates

Lipocine reports one-third enrollment in PPD treatment trial

Lipocine stock maintains Buy rating at H.C. Wainwright amid Phase 3 progress

Lipocine stock maintains Buy rating at H.C. Wainwright on PPD treatment potential